Back to Search
Start Over
COVID-19 in lymphangioleiomyomatosis: an international study of outcomes and impact of mTOR inhibition
- Source :
- Chest
- Publication Year :
- 2021
- Publisher :
- American College of Chest Physicians. Published by Elsevier Inc., 2021.
- Subjects :
- RT-PCR, reverse-transcription polymerase chain reaction
Lung Neoplasms
DLCO, diffusing capacity of the lungs for carbon monoxide
Tumor Suppressor Proteins
Settore MED/10 - Malattie dell'Apparato Respiratorio
BMI, body mass index
mTOR, mechanistic target of rapamycin
COVID-19
LAM
patient outcome assessment
FEV1, forced expiratory volume in the first second
Hospitalization
LAM, lymphangioleiomyomatosis
sirolimus
Tuberous Sclerosis Complex 2 Protein
FVC, forced vital capacity
Research Letter
UK, United Kingdom
Humans
Lymphangioleiomyomatosis
TSC, tuberous sclerosis complex
USA, United States of America
COVID-19, coronavirus disease 19
TSC
Subjects
Details
- Language :
- English
- ISSN :
- 19313543 and 00123692
- Database :
- OpenAIRE
- Journal :
- Chest
- Accession number :
- edsair.pmid.dedup....c55f307972bcb17e62cdac299d737bef